Tutorials › Adaptive Clinical Trial Design › Assessing Consequences of a Breach for Trial Credibility

Operational Bias and Trial Integrity · Tutorial 111 of 799

Assessing Consequences of a Breach for Trial Credibility

Learn to assess how a confirmed information breach may affect trial conduct, data, and conclusions without treating every disclosure as automatically invalidating the results.

Intermediate 11 min read

What You'll Learn

  • Separate the fact of disclosure from evidence of a consequence for trial credibility.
  • Assess what information was exposed, who received it, when exposure occurred, and what decisions recipients could influence.
  • Trace plausible pathways from exposure to recruitment, care, outcome assessment, data handling, or analysis.
  • Distinguish observed process changes from evidence that the breach caused those changes.
  • Document what remains uncertain and how that uncertainty limits interpretation of trial results.
  • Compare a focused impact assessment with blanket exclusion of data or a declaration that results are unaffected.

From Confirmed Breach to Consequence

A confirmed information breach establishes that information reached an unintended person or place; it does not, by itself, establish that trial conduct or results changed. The relevant question for credibility is narrower and more demanding: is there a plausible, evidence-supported pathway from the exposure to a change that could matter to the trial’s conclusions? A careful assessment neither dismisses a breach because no harm is immediately visible nor assumes that any disclosure invalidates the trial.

In an adaptive trial, an interim treatment comparison or a proposed adaptation may be sensitive because knowledge of it could affect future decisions. But the practical consequence depends on details: a recipient with no trial role may have no way to alter conduct; a person with an operational role may receive only information that cannot reveal treatment differences; or exposure may occur after the relevant decisions and outcomes are already fixed. The assessment must establish those details rather than infer consequences from the word “breach.”

Definition: A breach impact assessment is a documented evaluation of whether, how, and with what uncertainty an unauthorized disclosure could have affected trial conduct, data, analysis, or interpretation. It distinguishes verified facts about exposure from hypothesized pathways and from observed consequences.

A Four-Part Exposure Assessment

Begin with four linked questions. Record the answers using evidence such as access logs, message contents, role records, meeting minutes, decision records, and interviews. Mark unknowns as unknown; do not replace them with assumptions.

  1. What was disclosed? Identify the actual content and its level of detail. A message that names a treatment arm and reports a comparative response is different from a masked, pooled summary. Establish whether the recipient could identify treatment, infer a trend, see an unplanned analysis, or learn about an adaptation under consideration.
  2. Who received it? Identify each recipient and their responsibilities, access, and ability to influence trial decisions or participant-facing work. Include indirect exposure where someone forwarded, discussed, or acted on the information. A recipient’s job title alone is not proof that the person used or understood the information.
  3. When did exposure occur? Relate exposure to the timing of recruitment, treatment decisions, outcome assessment, data finalization, and any planned adaptation. Information can only influence a decision if it is available before that decision; late exposure may still affect analysis or interpretation if those remain open.
  4. Which process could have changed? Name a specific mechanism: for example, altered recruitment, differential care, changed outcome assessment, data handling, an adaptation decision, or analysis choices. State how the disclosed information could have produced the change, then look for records or patterns that support or contradict that account.

These questions form a chain, not a numerical risk score. If the content could not reveal a treatment difference, a proposed pathway through treatment-informed recruitment is weakened. If a recipient had no influence on recruitment, care, or assessment, that particular pathway is also weakened. If exposure preceded a consequential decision, an opportunity for influence existed, but opportunity alone does not establish that influence occurred. A weighted score that combines these facts can conceal which link is supported and which is speculation.

1
Establish the exposure.
Preserve the source, content, access history, recipients, and timeline. Separate confirmed facts from unresolved scope.
2
Specify a mechanism.
For each potentially affected process, explain what the recipient could do differently because of the disclosed information.
3
Examine consequences.
Compare relevant records and process measures before and after exposure, accounting for other explanations and the timing of decisions.
4
State the credibility judgment.
Describe supported consequences, plausible but unverified pathways, evidence against impact, and remaining uncertainty. Escalate design-specific statistical questions to the appropriate review.

Why the Assessment Is a Causal Argument

A credibility assessment is not simply a search for an unusual result after the breach. It asks whether the trial might have proceeded differently without the exposure. Let \(Y(0)\) denote the process or result that would have occurred without the breach, and \(Y(1)\) the process or result under the exposure that actually occurred. Only one of these histories is observed for the trial. Therefore, an observed change after exposure cannot, by timing alone, prove that the breach caused it.

The logic of the assessment follows from that limitation. First identify a mechanism linking the disclosure to a decision or process. Then check whether the recipient had the information, opportunity, and relevant role for that mechanism. Finally, examine evidence about what changed and consider alternative explanations, such as a protocol amendment, site staffing change, or ordinary fluctuation. This does not reveal the unobserved \(Y(0)\) with certainty. It makes the causal claim more or less credible by testing its necessary links against available evidence.

$$ \text{disclosed information} \longrightarrow \text{recipient with relevant opportunity} \longrightarrow \text{changed process or decision} \longrightarrow \text{possible effect on data or inference} $$

The arrows describe a pathway to investigate, not a guarantee that each step occurred. A strong assessment reports the strength of evidence at each link instead of collapsing the entire chain into “affected” or “unaffected.”

Worked Example: Interim Information Reaches Staff With No Trial Role

Suppose a hypothetical adaptive trial accidentally sends a treatment-specific interim summary to two employees in a sponsor department that has no responsibility for the trial. The access log confirms that both opened the file. The summary shows response rates of 42% and 35% for the two groups at a planned interim review. Neither employee is on the adaptation committee, does not communicate with sites, and has no role in data management or analysis. The access log and interviews find no forwarding or discussion with trial personnel.

What was disclosed? The file contained treatment-specific response rates, so it was capable of revealing a comparative trend. Who received it? Two people with confirmed access, but no identified authority over trial processes. When? Before recruitment was complete, so timing alone does not rule out possible effects. Which process could have changed? A pathway through recruitment or adaptation would require information to reach people able to influence those decisions. The investigation has found no such connection.

On these hypothetical facts, the exposure is confirmed and the content is sensitive, but there is no supported pathway to changed trial conduct or analysis. The appropriate conclusion is not “nothing happened” as an absolute fact; it is that the available evidence does not identify a credible operational pathway, with the limits of the access and communication review recorded. If further evidence showed that an employee relayed the results to trial staff, the assessment would need to be updated.

Assessing Process Evidence and Trial Credibility

Evidence should be matched to the proposed mechanism. If the concern is recruitment, examine recruitment decisions and patterns around the exposure date, as well as documented reasons for changes. If the concern is assessment, examine assessor access, scoring records, deviations, and relevant care changes. If the concern is analysis, preserve versions, access records, decision logs, and the prespecified analysis plan. A trend or imbalance can be a signal to investigate, but it does not establish causation: ordinary variation, secular changes, and other operational events may also explain it.

Also distinguish the affected process from the affected result. A process deviation may be real but have no material bearing on the primary outcome; conversely, a change affecting only a limited number of participants may matter if it concerns a highly influential decision or a sensitive analysis choice. The assessment should explain why the affected population, outcomes, and decisions are or are not relevant to the trial’s target conclusions. It should not declare an analysis valid or invalid merely from a general impression of risk.

Assessment findingWhat it supportsWhat it does not establish alone
Unauthorized access is confirmedInformation reached an unintended recipientThat the recipient acted on it or that results changed
A recipient had influence over a relevant processA possible opportunity for the process to be affectedThat the opportunity was used or a change was caused
A process measure shifted after exposureA reason to investigate a proposed pathwayThat exposure caused the shift
No change is detected in reviewed recordsEvidence against some specified forms of impactThat all possible effects are absent, especially where records are incomplete

Worked Example: A Plausible Recruitment Pathway

Suppose, hypothetically, that a treatment-specific interim summary was sent to investigators at three sites while recruitment was active. The sites enrolled 28 participants in the four weeks before exposure and 12 in the four weeks after. The investigators could influence which eligible patients were approached. The records also show that two sites had temporary staffing shortages during the later period.

The difference in counts is \(28-12=16\) fewer enrollments after exposure across the three sites. That arithmetic describes the observed counts; it does not measure a breach effect. The exposure preceded recruitment decisions, recipients had a relevant role, and the disclosed comparison could plausibly affect expectations. These facts establish an opportunity and a mechanism worth examining. The staffing shortages are an alternative explanation that must also be considered.

A focused follow-up would compare site-specific recruitment records, approach and eligibility logs, documented reasons for non-enrollment, staffing dates, and communications after exposure. If records show that approach rates changed at a site after investigators discussed the treatment results, the causal concern would strengthen. If the decline is confined to sites with staffing shortages and records show no treatment-informed change in approach, the evidence for breach-related recruitment effects would weaken. Neither conclusion follows from the total counts alone.

Calibrating Conclusions and Choosing a Response

A useful conclusion distinguishes at least three states. Impact supported: evidence links exposure to a relevant changed process or decision. Impact plausible but unresolved: a credible pathway exists, but the available evidence cannot determine whether or how much it operated. No credible pathway identified on available evidence: examined facts do not support a material route from exposure to trial conduct or inference. These descriptions are not regulatory classifications; they are a disciplined way to make the reasoning and uncertainty visible.

The response should fit the pathway and the uncertainty. Preserve records and restrict further access in every case. Where a process may have changed, investigate the affected decisions and participants, document deviations, and obtain appropriate trial and statistical review before deciding how results should be interpreted. Do not silently remove participants or alter an analysis to make the breach appear harmless. Any decisions about additional analyses, exclusions, or design-specific inferential consequences require transparent justification and appropriate governance.

This focused assessment is preferable to two tempting alternatives. A blanket rule that every breach invalidates the trial ignores whether recipients could affect anything and may discard informative data without justification. The opposite rule—that results are unaffected unless a direct effect is proven—sets an unrealistic evidentiary threshold, because the no-breach history cannot be observed. A structured causal assessment instead makes a proportionate claim: what is known, what pathway is credible, what evidence bears on it, and what cannot be resolved.

Worked Example: Exposure After Relevant Decisions Were Fixed

Suppose, hypothetically, a blinded data-management employee receives a treatment-labelled interim table by mistake. The investigation confirms that the employee opened it after recruitment closed, all outcome assessments were completed, and the database was locked. The employee had no role in the final analysis and did not share the table. The analysis plan and code version had already been finalized, and access records show no later changes by that employee.

The content was sensitive and exposure is confirmed. The timing and role, however, weaken pathways through recruitment, care, and outcome assessment because those processes were complete. The proposed analysis pathway is also unsupported by the employee’s responsibilities and the records reviewed. The assessment can therefore conclude that no credible route to a change in the reviewed processes has been identified. It should still state that the conclusion depends on the completeness of the access and version records; it should not imply that confidentiality was maintained or that every conceivable consequence is impossible.

Common Pitfalls and Diagnostics

  • “The breach occurred, so the trial is invalid.” This confuses exposure with consequence. Identify a mechanism and evidence that connects it to a trial process before judging credibility.
  • “There was no obvious change, so there was no impact.” Absence of a detected change is informative only for the processes and records actually reviewed. Check whether monitoring could detect the proposed effect and whether the records are complete.
  • “The process changed after exposure, so the breach caused it.” Temporal order is necessary for many causal pathways, but it is not sufficient. Examine alternative events, site-level patterns, and evidence that recipients used or conveyed the information.
  • “The overall outcome looks similar, so the breach did not matter.” A similar aggregate result does not rule out biased recruitment, assessment, or analysis. Assess the pathway and relevant data rather than relying on a reassuring headline.
  • “A numerical risk score settles the question.” An arbitrary score can hide weak evidence or a missing link. Present the facts and uncertainty for each exposure and consequence dimension instead.

Diagnostics should therefore test both the proposed impact and the limits of the investigation: Were all recipients identified? Are timestamps reliable? Could information have been relayed verbally? Were process measures collected consistently? Are other operational changes documented? A credible report says when these questions remain unanswered and avoids turning incomplete evidence into certainty.

Key takeaway: Assess credibility by tracing what was disclosed, who could act on it, when they received it, and which trial process could have changed. Separate verified exposure, plausible mechanisms, observed consequences, alternative explanations, and unresolved uncertainty.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

  1. A treatment-specific interim summary reaches a site coordinator after the site has stopped recruiting but before outcomes are assessed. Name two relevant questions for judging whether outcome credibility could be affected.
  2. Recruitment falls after an exposure. Why is that observation insufficient to show that the breach caused the decline?
  3. A recipient opened a sensitive file but had no trial responsibilities and did not share it, according to the available access and communication records. What conclusion is appropriately supported?
  4. Why should an assessment report unknowns rather than treating missing access records as evidence that no one else received the information?
  5. State one limitation of comparing process measures before and after exposure.

Solutions. (1) Establish whether the coordinator could influence outcome assessment or care, and whether the disclosed content could plausibly influence assessment; also verify the timing of assessments and any onward communication. (2) The decline could reflect other events, such as staffing or enrollment changes. A temporal association is not proof of causation; examine site-level records, alternative explanations, and a plausible mechanism. (3) The breach and access are confirmed, but the available evidence identifies no credible pathway to a changed trial process through this recipient. Qualify the conclusion by the completeness of the records. (4) Missing records create uncertainty about exposure scope; they cannot establish that access did not occur. (5) Other events may coincide with exposure, and an aggregate before–after comparison may conceal site differences. The comparison is a diagnostic signal, not a causal estimate by itself.

Clinical Biostats